BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 10336504)

  • 1. Pharmacokinetic advantage of intra-arterial cyclosporin A delivery to vascularly isolated rabbit forelimb. I. Model development.
    Shirbacheh MV; Ren X; Jones JW; Breidenbach WC; Jevans AW; Fernandez-Botran GR; Maldonado C; Barker JH; Gruber SA
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1185-90. PubMed ID: 10336504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic advantage of intra-arterial cyclosporin A delivery to vascularly isolated rabbit forelimb. II. Dose dependence.
    Shirbacheh MV; Harralson TA; Jones JW; Breidenbach WC; Jevans AW; Maldonado C; Barker JH; Gruber SA
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1191-5. PubMed ID: 10336505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of intra-arterial delivery of tacrolimus to vascularly isolated rabbit forelimb.
    Shirbacheh MV; Jones JW; Harralson TA; Edelstein J; Tecimer T; Breidenbach WC; Jevans AW; Maldonado C; Barker JH; Gruber SA
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1196-201. PubMed ID: 10336506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of gastrointestinal inflammation and age on the pharmacokinetics of oral microemulsion cyclosporin A in the first month after bone marrow transplantation.
    Schultz KR; Nevill TJ; Balshaw RF; Toze CL; Corr T; Currie CJ; Strong DK; Keown PA
    Bone Marrow Transplant; 2000 Sep; 26(5):545-51. PubMed ID: 11019845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Intraocular implantation of cyclosporine A drug delivery system in the treatment of experimental uveitis].
    Dong XG; Xu YM; Yuan GQ; Shi WY; Xie LX; Wang SG
    Zhonghua Yan Ke Za Zhi; 2005 Jul; 41(7):636-41. PubMed ID: 16080900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uveal melanoma model with metastasis in rabbits: effects of different doses of cyclosporine A.
    Blanco G; Saornil AM; Domingo E; Diebold Y; López R; Rábano G; Tutor CJ
    Curr Eye Res; 2000 Sep; 21(3):740-7. PubMed ID: 11120562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A rat model designed for the continuous intraarterial infusion of cyclosporine.
    Fan JJ; Cao LG; Bi L; Pei GX
    Transplant Proc; 2015 Mar; 47(2):549-52. PubMed ID: 25769605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
    Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ
    Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New oral formulation of cyclosporin A (Neoral) pharmacokinetics in allogeneic bone marrow transplant recipients.
    Parquet N; Reigneau O; Humbert H; Guignard M; Ribaud P; Socié G; Devergie A; Espérou H; Gluckman E
    Bone Marrow Transplant; 2000 May; 25(9):965-8. PubMed ID: 10800064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Achieving adequate cyclosporine exposure in liver transplant recipients: a novel strategy for monitoring and dosing using intravenous therapy.
    Lück R; Böger J; Kuse E; Klempnauer J; Nashan B
    Liver Transpl; 2004 May; 10(5):686-91. PubMed ID: 15108262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymeric micelles for the solubilization and delivery of cyclosporine A: pharmacokinetics and biodistribution.
    Aliabadi HM; Brocks DR; Lavasanifar A
    Biomaterials; 2005 Dec; 26(35):7251-9. PubMed ID: 16005061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of converting from intravenous to oral administration of cyclosporin A in pediatric allogeneic hematopoietic stem cell transplant recipients.
    Choi JS; Lee SH; Chung SJ; Yoo KH; Sung KW; Koo HH
    Bone Marrow Transplant; 2006 Jul; 38(1):29-35. PubMed ID: 16715103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective cross-over study comparing the pharmacokinetics of cyclosporine A and its metabolites after oral versus short-time intravenous cyclosporine A administration in pre-heart transplant patients.
    Lehle K; Kirchner GI; Rupprecht L; Gruber M; Birnbaum DE; Schmid FX; Preuner JG
    Transplant Proc; 2007 Dec; 39(10):3323-8. PubMed ID: 18089380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local toxicity of hepatic arterial infusion of hexokinase II inhibitor, 3-bromopyruvate: In vivo investigation in normal rabbit model.
    Chang JM; Chung JW; Jae HJ; Eh H; Son KR; Lee KC; Park JH
    Acad Radiol; 2007 Jan; 14(1):85-92. PubMed ID: 17178370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An in vitro flow model to study streaming during pelvic intra-arterial drug infusions.
    Lutz RJ; Epstein AH; Cook JA; Dedrick RL
    Gynecol Oncol; 1995 Nov; 59(2):288-96. PubMed ID: 7590489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic monitoring of intravenous cyclosporine A in pediatric stem-cell transplant recipients. The trough level is not enough.
    Schrauder A; Saleh S; Sykora KW; Hoy H; Welte K; Boos J; Hempel G; Grigull L
    Pediatr Transplant; 2009 Jun; 13(4):444-50. PubMed ID: 18482216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of living donor liver transplant patients using twice-daily 4-hour intravenous cyclosporine therapy.
    Sato K; Iwane T; Sekiguchi S; Nakamura A; Akamatsu Y; Kawagishi N; Miyagi S; Takeda I; Sato A; Fujimori K; Satomi S
    Transplant Proc; 2009; 41(1):229-32. PubMed ID: 19249521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The simultaneous infusion of drugs via the left and right vertebral artery of the cat; a modified animal model for the study of possible central actions of drugs upon the lower brain stem.
    Porsius AJ
    Arch Int Pharmacodyn Ther; 1980 Dec; 248(2):260-71. PubMed ID: 7224708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transscleral Coulomb-controlled iontophoresis of methylprednisolone into the rabbit eye: influence of duration of treatment, current intensity and drug concentration on ocular tissue and fluid levels.
    Behar-Cohen FF; El Aouni A; Gautier S; David G; Davis J; Chapon P; Parel JM
    Exp Eye Res; 2002 Jan; 74(1):51-9. PubMed ID: 11878818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacokinetics of adriamycin by bronchial artery infusion for non-small cell bronchogenic carcinoma].
    Wang T; Yang H; Wang H
    Zhonghua Zhong Liu Za Zhi; 2001 Sep; 23(5):395-8. PubMed ID: 11810771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.